Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL
In: Blood Advances, Jg. 8 (2024-06-11), Heft 11, S. 2846-2860
Online
academicJournal
Zugriff:
Titel: |
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL
|
---|---|
Autor/in / Beteiligte Person: | Gentile, Gaia ; Poggio, Teresa ; Catalano, Antonella ; Voutilainen, Minna ; Lahnalampi, Mari ; Andrade-Martinez, Marta ; Ma, Tobias ; Sankowski, Roman ; Goncharenko, Lina ; Tholen, Stefan ; Han, Kyuho ; Morgens, David W. ; Prinz, Marco ; Lübbert, Michael ; Engel, Sophia ; Hartmann, Tanja Nicole ; Cario, Gunnar ; Schrappe, Martin ; Lenk, Lennart ; Stanulla, Martin ; Duyster, Justus ; Bronsert, Peter ; Bassik, Michael C. ; Cleary, Michael L. ; Schilling, Oliver ; Heinäniemi, Merja ; Duque-Afonso, Jesús |
Link: | |
Zeitschrift: | Blood Advances, Jg. 8 (2024-06-11), Heft 11, S. 2846-2860 |
Veröffentlichung: | 2024 |
Medientyp: | academicJournal |
ISSN: | 2473-9529 (electronic) |
DOI: | 10.1182/bloodadvances.2023011582 |
Sonstiges: |
|